Dr Reddys Laboratories Share Price Today - Live Blog for May 05, 2025

Dr Reddys Laboratories Ltd's shares saw an increase of 0.03%, reaching the current market price of ₹1,172.00. This development underscores the stock's growing popularity.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.21%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,173.00 per share.

Dr Reddys Laboratories Ltd share price has declined by -0.10%, and it's currently trading at ₹1,170.40. The stock maintains a PE of 18.3800, while the industry PE is 34.3056, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.18% increase and currently trading at ₹1,172.45 per share. This upward trajectory is turning heads in the market.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.09% recently. As of now, this stock is actively trading at a current market price of ₹1,170.40 per share, attracting attention from investors.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.06% increase. Presently, it is actively trading at ₹1,169.30.

Dr Reddys Laboratories Ltd share price surged by 0.14%. With its current market price standing at ₹1,169.40 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd experienced a -0.02% dip in its share price and is currently trading at ₹1,167.75. The stock has a PE ratio of 18.3800, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Demonstrating a commendable 0.24% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,168.25. In terms of valuation, the stock maintains a PE ratio of 18.3800, while the industry PE ratio stands at 34.3056.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.31%, reaching a current market price of ₹1,165.55. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

After a notable 0.02% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,169.30. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.10%, reaching the current market price of ₹1,168.80. This ascent signifies increased investor sentiment. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.16% in its share price, and it currently trades at ₹1,167.65 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

The share price of Dr Reddys Laboratories Ltd plunged by -0.07%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,167.80, but investors are assessing whether this is a temporary dip or a long-term trend.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.20% boost, with the current market value at ₹1,168.65 per share. This surge has not gone unnoticed by investors.

After a notable 0.05% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,166.70. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

Dr Reddys Laboratories Ltd's share price has dropped by -0.00%, a development that warrants careful analysis. Presently trading at ₹1,166.10, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd's stock has surged by 0.25%, and it is currently trading at ₹1,166.90. Additionally, the stock maintains a PE ratio of 18.3800, while the industry PE is 34.3056.

Dr Reddys Laboratories Ltd witnessed a -0.17% drop in its share price and is currently trading at ₹1,164.15. With the stock's PE at 18.3800 and the industry PE at 34.3056, investors are weighing their options.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.13% drop, and it's now trading at ₹1,165.50 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The share price of Dr Reddys Laboratories Ltd experienced a -0.68% slump and is currently trading at ₹1,168.05. While the stock maintains a PE ratio of 18.3800, the industry PE is 34.3056, raising questions about valuation.

The stock of Dr Reddys Laboratories Ltd suffered a -0.32% drop, and it's now trading at ₹1,176.10 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Demonstrating a commendable 0.21% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,179.75. In terms of valuation, the stock maintains a PE ratio of 18.3800, while the industry PE ratio stands at 34.3056.

Dr Reddys Laboratories Ltd stock price decreased by -0.12%, with the current market value at ₹1,176.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.08% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,180.00 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 6.82%. At this moment, it's actively trading at ₹1,175.05, presenting an enticing opportunity for those in the market.